In such tauopathies and α-synucleinopathies, occurrence of TDP-43-positive neuronal cytoplasmic inclusions may be associated with other distinct molecular pathologic processes primarily involving their own pathological proteins, tau and Torin 1 supplier α–synuclein, respectively (secondary TDP-43 proteinopathies). On the other hand, in several polyglutamine (polyQ) diseases, TDP-43 appears to play an important pathomechanistic role. Interestingly, intermediate-length polyQ expansions

(27–33 Qs) in ataxin 2, the causative gene of spinocerebellar ataxia type 2, have recently been reported to be a genetic risk factor for SALS. Here, with a review of the literature, we discuss the relationship between ALS and polyQ diseases from the viewpoint of TDP-43 neuropathology. In 2006, two independent groups identified transactivation response (TAR) DNA binding protein

43 kDa (TDP-43) as a click here major component of ubiquitin-positive neuronal cytoplasmic inclusions (NCIs) in frontotemporal lobar degeneration with ubiquitin inclusions (FTLD-U) and sporadic amyotrophic lateral sclerosis (SALS),[1, 2] and suggested that TDP-43 might be a specific marker for these diseases. However, Arai et al. later reported that round NCIs, i.e. Pick bodies, in Pick’s disease, may sometimes be positive for TDP-43.[1] Since then, it has become evident that TDP-43-positive NCIs can be detected in cases of many other neurodegenerative diseases, including Alzheimer’s disease (AD),[3-10]

corticobasal degeneration (CBD),[10] progressive supranuclear palsy (PSP),[11] and Lewy body-related diseases (LBD).[4, 12-14] In these diseases, unlike FTLD-U (now designated FTLD-TDP) and ALS, such inclusions have been observed almost exclusively in the limbic system, including the hippocampus, amygdala and adjacent cortices, suggesting that TDP-43 pathology may involve distinct molecular processes in which the disease proteins, tau and α-synuclein (secondary TDP-43 proteinopathies), play central roles. However, in polyglutamine (polyQ) diseases such as Huntington’s disease (HD), Schwab et al. have reported the presence of TDP-43-positive inclusions in the cerebral neocortices,[15] and it has recently been recognized Selleckchem Lumacaftor that TDP-43 has some influence on the production of polyQ pathology.[16] Furthermore, we have reported that the occurrence of TDP-43 pathology with a distribution pattern similar to that seen in SALS, is a feature of spinocerebellar ataxia type 3 (SCA3)/Machado-Joseph disease (MJD)[17] and SCA2,[18] and that both HD and SALS can occur in the same patient.[19] From these findings, we assume that TDP-43 affects polyQ via a specific pathogenetic pathway that is distinct from those in other neurodegenerative diseases such as AD and LBD. Here, with a review of the literature, we discuss the TDP-43 pathology of neurodegenerative diseases, with special reference to the polyQ diseases.

1A). Both immunization protocols generated NP118-specific memory CD8+ T cells with similar frequency, phenotype (CD127hi, KLRG-1lo, CD27hi, CD43lo), and functionality (IFN-γ, TNF, and granzyme B expression; Fig. 1B–D). Mice from both vaccinated groups and nonimmunized controls were then challenged with LCMV-Arm. Consistent with our previous results [[16]], the NP118-specific CD8+ T cells in the att LM-NP118-vaccinated PKO mice underwent massive expansion, constituting ∼75% of all CD8+ T cells in the spleen (∼ 6–7×107 per spleen), at day 5 after LCMV challenge (Fig. 1C and D). One hundred percent

of these mice succumbed to the infection based CYC202 molecular weight on morbidity criteria by day 11 post-LCMV challenge (Fig. 1E). In sharp contrast, nonimmunized PKO mice exhibited relatively modest expansion of NP118-specific CD8+ T cells at day 5 post-LCMV infection and none of these mice succumbed (Fig. 1C–E). Interestingly, massive expansion of NP118-specific CD8+ T cells was also observed in DC-NP118-vaccinated mice and all of those mice succumbed to LCMV infection (Fig. 1C–E). Finally, the NP118-specific secondary effector CD8+

T cells at day 5 post-LCMV challenge exhibited similar phenotypes in the two vaccinated groups (Fig. 1F). These results suggest that mortality in vaccinated PKO mice following LCMV-Arm challenge is independent of immunization modalities. MycoClean Mycoplasma Removal Kit Current literature suggests that the magnitude of CD8+ T-cell expansion after primary infection is related to the number of precursors recruited into the response [[32, 33]]. However, check details it remains unclear whether the number of LCMV-specific memory CD8+ T cells at the time of LCMV infection determines the magnitude of secondary expansion and subsequent mortality in PKO mice. To address this question, we generated different levels of memory CD8+ T cells either by varying

the dose of att LM-NP118 used for immunization or by adoptive transfer of different numbers NP118-specific memory CD8+ T cells into naïve PKO mice. Naïve PKO mice were immunized with 5 × 106 CFU (high dose) or 5 × 102 CFU (low dose) of att LM-NP118. In order to control the extent of inflammation elicited by two different doses of infection used, mice that received a low dose of att LM-NP118 were coinfected with 5 × 106 CFU of the att LM strain that does not express the NP118 epitope (Fig. 2A). Approximately fourfold fewer NP118-specific memory CD8+ T cells (detected in PBL) were present in “low dose” compared with “high dose” immunized groups of mice (Fig. 2B). At day 70 post infection (p.i.) mice from both experimental groups and an additional control (nonimmunized) group were challenged with LCMV-Arm. Despite having fourfold difference in starting memory numbers (Fig.

Access is free to all residents of countries in the World Bank’s list of low-income economies (countries with a gross national income per capita of less than $1000), through a system which recognizes a users country of origin.

The Cochrane Renal Group is responsible for Navitoclax cell line production and maintenance of all Cochrane Library resources relevant to kidney disease, as well as supporting authors of reviews, and is based in Sydney, Australia (see http://www.cochrane-renal.org/). A list of Cochrane Renal Group systematic reviews can be found by entering The Cochrane Library and browsing by ‘topic’ and then selecting ‘renal’. The Health InterNetwork Access to Research Initiative (HINARI), a partnership led by the World Health Organization, provides free or very low cost online access to the major journals in biomedical and Selleck Idelalisib related social sciences to local, not-for-profit institutions in developing countries. Access to more than 6200 journals and other full-text resources from more than 150 publishers, including The Cochrane Library databases are available from http://www.who.int/hinari/about/en/. The International Network for the Availability of Scientific Publications’ (INASP, http://www.inasp.info/) focuses on communication, knowledge and networks, with particular emphasis on the needs of developing and

emerging countries. INASP provides access to many scientific resources, including health information, funded by its partner countries, governmental and non-governmental development agencies, and philanthropic foundations. It is also worth investigating what your professional society memberships entitle you to. Most societies

check produce a professional journal, and chances are it is available online. Some of the regional national societies of nephrology that are affiliated with the Asia Pacific Society of Nephrology include access to this journal as part of subscriptions fees. For others, a small additional subscription provides online and print access. For members of the International Society of Nephrology, a variety of educational resources, including journal access, are available via the nephrology gateway (see http://www.nature.com/isn/index.html). Kidney Disease Improving Global Outcomes (KDIGO; http://www.kdigo.org), provides access to an interactive, easily accessible database of existing clinical practice guidelines in nephrology, and includes a facility to compare guideline recommendations from around the world (http://www.kdigo.org/nephrology_guideline_database). It includes links to guidelines from Caring for Australians with Renal Impairment (CARI), Canadian Society of Nephrology (CSN), Kidney Disease Outcomes Quality Initiative (KDOQI), Renal Physicians Association (RPA), Renal Association (UK), International Society of Peritoneal Dialysis (ISPD) and European Best Practice Guidelines (EBPG).

Likewise, the /puk/ tokens were modified to have VOTs of approximately 70 msec (M = 69 msec, SD = 2). These values are as identical

to the means from Experiments 1 and 2 as was technically possible, and the difference between the means again mimics both exemplar sets in Rost and McMurray. For the half of the tokens naturally produced with VOTs shorter than 70 msec, aspiration was copied from the center of the aspirated period and spliced again into the sound file to increase the total VOT. For tokens with VOTs longer than 70 msec, aspiration was cut from the center of the aspirated period. Stimuli in the /buk/ category varied in length from 217 to 705 msec, GPCR Compound Library with a mean length of 425 msec (SD = 11). Stimuli in the /puk/ category varied in length from 339 to 765 msec, with a mean of 487 (SD = .11). The length of the vocalic portion (measured from voicing onset to closure) between the two categories did not differ (/buk/M = 237 msec, SD = 7; /puk/M = 220 msec, SD = .8, t = 1.09, p = .27), indicating that

the mean difference of 62 msec between the /buk/ and /puk/ word sets was caused by the experimentally manipulated VOT difference between them. The order of these items within and across trials was pseudo-randomized using a MATLAB script so that infants heard 36 different exemplars of each word in random sets of seven per trial during the habituation phase and seven (previously unheard) exemplars of each word in random order

during the test. These presentations were again at 2-sec selleck screening library intervals for fixed habituation trials of 14 sec. Experimental set-up and procedures were identical to Experiment 1, with the exception that all tokens were equally probable (for a given word). Data were collected and analyzed in the same manner as in Experiment 1. Figure 2 displays the results. A repeated measures ANOVA revealed a main effect of test condition, F(2, 24) = 22.7, p < .001. Planned comparisons revealed that this effect was driven by the fact that infants looked to the switch trial (M = 7.16 sec, SD = 4.06) significantly longer than the same trial (M = 4.19 sec, SD = 1.98), F(1, 12) = 8.1, p = .015. Unlike Experiments 1 and 2-hydroxyphytanoyl-CoA lyase 2, they dishabituated to the switch: that is, they represented both words well enough to notice the misnaming. Similar to the prior experiments, infants also looked to the control trial (M = 9.63 sec, SD = 3.17) longer than the same and switch trials, F(1, 14) = 57.7, p < .001. Importantly, we found no effect of test order (F < 1) or switch test word (/buk/ or /puk/, F < 1), and no two- or three-way interactions (all F < 1). Dishabituation to the switch trials can not be attributed to test order or word preference. One concern was whether the highly salient speaker variability caused the infants in Experiment 3 to take longer to habituate than those in the prior experiments.

Adoptively transferred p14 CD8+ T cells coexpressed CD44, PD-1 and IL-7Rα as analyzed by FACS analysis of blood (Fig. 2G, Supporting Information Fig. 2C) and spleens (data not shown) 5 days after transfer. Thus, CML-specific CTL display an activated phenotype but retain IL-7Rα click here expression. The fact that specific CTL downregulate IL-7Rα expression in the presence of a chronic infection but maintain IL-7Rα expression in the presence of CML expressing the same viral antigen was surprising and led

to the question if IL-7 production is increased in CML mice. To analyze this, we compared IL-7 expression in mRNA isolated from spleen of CML and naïve C57BL/6 mice by RT-PCR. The thymus as organ with documented high IL-7 production served as a positive control. IL-7 mRNA was detectable in the spleen of CML and of naïve C57BL/6 mice (Fig. 3A and Supporting Information Fig. 3). Next, we analyzed whether IL-7 mRNA is detectable in CML granulocytes and in control granulocytes. We therefore quantitatively compared IL-7 mRNA production of sorted GFP+ granulocytes from CML mice with sorted granulocytes from C57BL/6 mice.

Surprisingly, IL-7 mRNA was detectable in both malignant and control granulocytes (Fig. 3B). Moreover, this experiment revealed that IL-7 mRNA was not differently expressed in malignant and in normal granulocytes. However, the total number of granulocytes in the spleen of mice with CML is three to four-fold higher than that found in C57BL/6 control mice (Fig. 3C). These findings were confirmed by quantification of IL-7 protein levels per check details milligram spleen of naïve C57BL/6 mice and CML mice (Fig. 3D). Furthermore, IL-7 was detectable by intracellular staining of brefeldin-treated malignant (GFP+) and normal (GFP−) granulocytes but not in granulocytes from IL-7-deficient mice (MFI increase of IL-7 in Reverse transcriptase GFP− granulocytes (12.4±2.9%) and GFP+ granulocytes (11.4±2.9%)

(Fig. 3E and F)). Taken together, the malignant granulocytes produce IL-7 and are increased in numbers in secondary lymphoid organs such as the spleen. To study the role of IL-7 produced by leukemic cells in more detail, H8×IL-7-deficient mice were used as bone marrow donors (H8×IL-7−/−-CML mice) to establish CML disease in C57BL/6 recipients. In this experiment, the leukemic cells will not produce IL-7. However, stromal and epithelial cells of the recipient mouse are capable of IL-7 secretion. Purified p14 CD8+ T cells (CD45.1+CD8+Vα2+) were adoptively transferred to H8×IL-7−/−-CML mice, H8-CML and naïve C57BL/6 mice. P14 CD8+ T cells expanded similarly in H8×IL-7−/−-CML mice and in H8-CML mice (Fig. 4A). However, significantly more p14 CTL survived long term in H8-CML mice than H8×IL-7−/−-CML mice (analyzed in blood: H8-CML: 8.2±3.7%; H8×IL-7−/−-CML: 1.2±0.6%; p=0.04).

This result contrasts with the effects of simvastatin on SOCS3 induction that were maximal after 24 hr of stimulation. When we examined the effects of simvastatin on the early events in the TGF-β signal transduction cascade, we did not observe any augmentation of Smad3 phosphorylation. In contrast, the major effects of simvastatin were associated with a decreased induction of Smad6/7, inhibitory Smads that inhibit TGF-β signalling by blocking the phosphorylation of Smad2/3.

We favour the view that simvastatin can directly block the induction of Smad6/7 expression, as the drug also inhibited the induction of Smad6/7 at 72 hr in the presence of a TCR signal alone in the absence of TGF-β. Alternatively, it is possible that the effects of simvastatin on Smad6/7 expression are mediated indirectly via a direct effect on Foxp3 expression as Fantini et al.22 have Midostaurin in vitro demonstrated that transfection of Foxp3 is capable of blocking TGF-β-induced Smad7 expression by acting directly on the Smad7 promoter. This mechanism is consistent with our findings that Smad6/7 cannot be induced in Foxp3+ nTregs following TGF-β signalling. Although it is difficult to extrapolate from our in vitro model systems to the in vivo situation, our results that simvastatin can markedly

enhance the induction of Foxp3 expression selleck compound in the presence of Edoxaban low concentrations of TGF-β strongly suggest that some of the beneficial effects of simvastatin include the generation of Tregs in the inflammatory milieu of the atherosclerotic

plaque. Further analysis of the mechanism of action of simvastatin will require identification of the targets of geranylgeranylation at different time-points after T-cell activation. Ras, Rho, CDC42 and many different GTPases are important for early signal transduction after engagement of the TCR and may play a role in induction of SOCS3. However, our findings suggest that the effects of simvastatin are on proteins synthesized 24 hr after TCR stimulation. At the very least, our study strongly implies that an analysis of TCR-specific protein prenylation is a potential pathway for pharmacological manipulation of Tregs in vivo. This study was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health (Bethesda, MD). The authors have no conflict of interest. Figure S1. Simvastatin does not induce cell death or alter the cell cycle of Foxp3− cells. “
“The composition of the peripheral blood lymphocyte compartment underlies developmental changes during ontogeny. Recently, several new B cell populations have been characterized which were suggested to develop in an age-dependent manner. However, age-dependent reference values for distinct B cell populations have rarely been reported.

had strong antimicrobial activity against bacterial (B. subtilis, S. aureus, Sarcina luta and Pseudomonas sp.) and fungal strains

(C. albicans and Aspergillus niger). The clinical strains of S. aureus (1–10) were found to be positive for various biochemical tests: the coagulase test, mannitol utilization test, DNase test and catalase activity. The antibiotic-resistant profile of S. aureus (1–10) was determined using commercial antibiotics such as methicillin, penicillin and vancomycin. The S. aureus strain 7 was sensitive to methicillin; all other strains (1–6 and 8–10) were resistant to methicillin. All S. aureus strains (1–10) were resistant to penicillin. Strains 6, 8 and 9 were resistant to vancomycin; Ferrostatin-1 mw the other strains (1–5, 7 and 10) were sensitive to vancomycin. The hexane and ethyl acetate fungal extracts had no antibacterial activity against multidrug-resistant S. aureus strains. But the methanol extract of C. gloeosporioides showed an effective antibacterial activity against S. aureus strains. A maximum inhibition zone of 20 mm was observed against S. aureus strain 9 and a minimum inhibition zone of 12.3 mm was observed against strain 5 (Table 2). The control (DMSO) had no inhibitory activity against S. aureus strains. Similarly, Singh et al. (2000) reported that guanacastepene compound produced by the unidentified endophytic fungus CR115 had significant antibacterial activity

against MRSA and vancomycin-resistant Enterococcus faecium. Recently, Schneider et al. (2010) reported that the plectasin selleck chemicals antibiotics of fungal origin exhibited broad-spectrum activity against Gram-positive strains, including multidrug-resistant strains. This antibiotic especially binds with the bacterial cell-wall precursor Lipid II. The lowest concentration of fungal extract at which no growth of microorganism was observed upon visual observation after

incubating at 37 °C for 18 h is considered the MIC value. Pellets formed on the bottom of wells were considered bacterial growth even if the wells were clear of turbidity. The lowest MIC value of 31.25 μg mL−1 and the highest MIC value of 250 μg mL−1 were observed against S. aureus strain 9 and S. aureus strains 4 and 10, respectively (Table 3). Phongpaichit et al. (2006) reported an MIC value of 32–512 μg mL−1 of ethyl acetate extract of endophytic fungi Histone demethylase isolated from Garcinia sp. against MRSA. The combination of methanol extract with vancomycin and pencillin worked synergistically against methicillin-, penicillin- and vancomycin-resistant S. aureus strain 6. The FICI of all synergistic combinations calculated from the results of the chequerboard titre assays is shown in Table 4. The MIC values of fungal extract and vancomycin against S. aureus strain 6 were 62.5 and 30 μg mL−1, respectively, whereas the MIC values of fungal extract and vancomycin in synergistic combination against S. aureus strain 6 were 7.8 and 7.5 μg mL−1, respectively.

2). The data imply that radiotherapy upregulates the expression of Akt in the Tregs of BCa. A portion of the isolated cells in Fig. 1 was analysed by flow cytometry for the frequency of apoptotic Tregs. The results showed that much less frequency of apoptotic Tregs was detected in RA group than in the

nRA group (Fig. 3). The results implicate that radiation promotes the Treg survival in the cancer that may be via preventing the apoptotic activities in the Tregs. To further investigate the mechanism by which radiation promotes the survival of Tregs in BCa tissue, we generated CD4+ CD25+ Foxp3+ Tregs from human peripheral mononuclear cells. After treated with radiation (RA group), the levels of Akt were markedly increased in activated Tregs in a radiation dose-dependent manner. The frequency of apoptotic Tregs was also less among the Tregs of RA group than nRA group; the latter Cabozantinib mouse was activated, but not treated with radiation. Considering the increase in Akt might protect the Tregs from becoming apoptosis during radiation, some cells were treated with Akt inhibitor during the activation and radiation. Indeed, the frequency of apoptotic Tregs in RA group was similar to that of the nRA group (Fig. 4). The results indicate that RA can significantly increase the expression of Akt in Tregs that efficiently prevents Tregs to be apoptotic. This study revealed a side effect of radiotherapy

in the treatment for BCa. After radiation, MK-2206 supplier the frequency of the tumour infiltration Tregs significantly

increased in the BCa tissue. The levels of Akt were increased in the Tregs, which suppressed the sensitivity to apoptosis in Tregs. The tumour-infiltrating T cells play an important role in tumour growth. CD8+ T cells can inhibit ID-8 tumour growth by inducing tumour cell death or apoptosis. However, Tregs can inhibit CD8+ T cells in the tumour tissue that facilitates the tumour survival. Kaycer et al. [11] analysed a group of tumour-infiltrating T lymphocytes in non-small cell lung cancer and found that high numbers of Tregs were of beneficial prognostic influence in patients with non-small cell lung cancer. Boorjian et al. [12] observed a group of patients with liver cancer and found that the high frequency of Tregs in the tumour tissue was correlated with poor survival rate of the patients. Thus, to elucidate the causative factors increasing Tregs in tumour tissue is of significance. Yang et al. [13] found that colorectal cancer expressed high levels of integrin alpha versus beta 6, which had positive correlation with the frequency of Tregs in the tumour tissue. Our data have contributed one more novel evidence that radiotherapy also favours the increase in Treg in Bca tissue. Radiotherapy is an important therapeutic remedy in the treatment for malignant tumours. Because of its side effects, high doses of radiation should be avoided.

Monocytes expressing an anti-inflammatory phenotype have been observed

in vivo [11, 20]. Whether GA induces anti-inflammatory MG-132 mw monocyte phenotypes directly or via modulation of other cell types has been unclear. Previous reports show that stimulation of anti-inflammatory/regulatory T cells by GA-modulated APC depends on MHC class II–restricted antigen presentation. However, MHC class II is not required to facilitate GA-dependent anti-inflammatory monocyte functions, suggesting that induction of anti-inflammatory monocyte function by GA does not require T cells [11]. Our data show that GA is able to further reduce proliferation of self-reactive T cells by directly enhancing T cell suppression by monocytes. Monocyte-like cells with the ability to suppress immune responses have been described in a variety of experimental models including tumours [31], allograft rejection [32], experimental autoimmune myocarditis [33] and EAE [34]. Furthermore, freshly isolated naïve blood monocytes [15] as well as monocytes generated in culture

from naïve bone marrow [33] exhibit the ability to suppress in vitro T cell proliferation. Here, we show that GA directly modulates monocytes in vivo in an MHC class II–independent manner, resulting in enhanced T cell suppressive function. Importantly, this suppressive ability does not depend on the presence of antigen in the culture, thus expanding on the findings of Weber et al. [11] concerning the role of monocytes in counteracting autoimmunity during GA treatment. Autoimmunity is associated with a Bcl-w break in tolerance resulting in the inappropriate expansion of self-reactive Protein Tyrosine Kinase inhibitor T cells. It has recently been shown that loss of constitutive monocyte-dependent suppression of autoreactive T cell activation may be a contributing factor in the development of EAE in mice [20]. Interestingly, a reduction in T cell proliferation has been suggested to be part of the mechanism by which GA ameliorates MS. In the light of

current and earlier findings [11], it appears that GA treatment plays a key role in re-establishing type II suppressor function as well as the ability to directly suppress T cell proliferation by monocytes and thereby recover the tolerance to self-antigens. Previous in vitro studies have provided evidence of direct binding of GA to MHC class II [35], although the functional relevance of this binding is controversial. Our data show that MHC class II is not required for either GA binding or enhanced suppressor function of blood monocytes in vivo following intravenous GA administration. The fast rate of binding of GA to the blood monocytes indicates that GA uptake is likely to be cell surface receptor mediated rather than via less specific mechanisms such as macropinocytosis. Although GA binding to αMβ2 integrin on human monocytes has been reported in vitro [36], in this study, we only observed binding of GA to blood monocytes in vivo.

When we observed RBC velocity in 38 individual capillaries, 10 capillaries exhibited slowed-down RBC during CSD and RBC velocity Barasertib clinical trial remained low in 2 even after the passage of CSD. On the other

hand, RBCs with moderately (<3 mm/sec) or remarkably (>3 mm/sec) increased velocities were seen in 10 and 5 capillaries, respectively. Conclusion:  CSD-induced excitation of neurons may sustainably decrease or greatly increase RBC velocity in capillaries. “
“Microcirculation (2010) 17, 311–319. doi: 10.1111/j.1549-8719.2010.00027.x Objective:  The aim was to investigate the existence of sacral tissue blood flow at different depths in response to external pressure and compression in elderly individuals using a newly developed optical probe prototype. Methods:  The tissue blood flow and tissue thickness in the sacral area were measured during load in 17 individuals using laser Doppler flowmetry and photoplethysmography in a combined probe, and digital ultrasound. Results:  The mean age was 68.6 ± 7.0 years. While loading, the mean compression was 60.3 ± 11.9%. The number of

participants with existing blood flow while loading increased with increased measurement depth. None had enclosed blood flow deep in the tissue and at the same time an existing more superficial blood flow. Correlation between tissue thickness and BMI in unloaded and loaded sacral tissue was shown: r = 0.68 (P = 0.003) TSA HDAC clinical trial and r = 0.68 (P = 0.003). Conclusions:  Sacral tissue

is highly compressed by external load. There seems to be a difference in responses to load in the different tissue layers, as occluded blood flow in deeper tissue layers do not occur unless the blood flow in the superficial tissue layers is occluded. “
“Please cite this paper as: Gould DJ, Reece GP. Skin graft vascular maturation and remodeling: a multifractal approach to morphological quantification. either Microcirculation 19: 652–663, 2012. Objective:  One important contributor to tissue graft viability is angiogenic maturation of the graft tissue bed. This study uses scale-invariant microvascular morphological quantification to track vessel maturation and remodeling in a split-thickness skin-grafting model over 21 days, comparing the results to classical techniques. Methods:  Images from a previous study of split-thickness skin grafting in rats were analyzed. Microvascular morphology (fractal and multifractal dimensions, lacunarity, and vessel density) within fibrin interfaces of samples over time was quantified using classical semi-automated methods and automated multifractal and lacunarity analyses. Results:  Microvessel morphology increased in density and complexity, from three to seven days after engraftment and then regressed by 21 days. Vessel density increased from 0.07 on day 3 to 0.20 on day 7 and then decreased to 0.06 on day 21. A similar trend was seen for the fractal dimension that increased from 1.56 at three days to 1.